The Society of Interventional Radiology (SIR) announced the publication of a position statement that provides evidence-based ...
Siemens Healthineers announced it has received FDA clearance for six new systems in its Artis interventional imaging ...
HistoSonics announced it has submitted a de novo request to the FDA seeking authorization to expand the use of its Edison ...
Data from the PROMISE III trial suggest that chronic limb-threatening ischemia (CLTI) patients with no other treatment ...
Rapid Medical announced full results from the DISTALS randomized clinical trial demonstrating that the company’s Tigertriever ...
Cordis announced the launch in Japan of the Selution SLR percutaneous transluminal angioplasty (PTA) drug-eluting balloon ...
In the CARPOOL study, radial-to-peripheral (R2P) access achieved procedural success rates comparable to traditional common ...
Solaris Endovascular, Inc. announced that the FDA has granted Breakthrough Device designation for its Solaris DE drug-eluting ...
A comparative analysis from the ENGULF trial demonstrated that using blood return during continuous aspiration thrombectomy ...
April 29, 2026—enVVeno Medical Corporation announced it has received an FDA investigational device exemption (IDE) for the pivotal study of the ...
Teleflex Incorporated announced that Jason Weidman has been appointed President and Chief Executive Officer, effective June 8 ...
News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results